Mistake to post about the board basher. Just place him on IGNORE and move on.
Good info. Heck we need a frigin waiver/deferral or lets get the PIP completed.
So ACAD is not exactly " priced to sell ", I agree. Its high. I was expecting no higher than $15,000/yr. But one sales technique is to make people think they are getting a bargain by giving them a "discount ". Remember, the USA subsidizes the world. So the EU will need to be patronized. They expect it, we always come to their rescue and many times we expect to be treated like #$%$ from all other countries with few exceptions. Sorry that was probably OT. At any point, Acadia can always give an " introductory " price. Not to mention lower the price and the sales pick up. The price will decrease with time, they always do. Another OT: My friend use to approach women on the street in Hollywood. He knew his mark. A young women with their mom. He would offer them Pots & Pans. if they seemed interested he would then say..." You know what, I have an extra set of dishes in my trunk that I will give you if you buy the pots & pans ". He made a ton....the funny thing is they were going to get the dishes anyway.
So the MM gave the buyer a discount for buying $7.56Million worth of shares, it was the AH LOW.
Trades AFTER that sale went right back up over $29...
16:47 $ 29.81 High 50
16:45 $ 29.63 475
16:45 $ 29.804 11,310
Oh no, its help get the word out , gives all the FDA info, including Black Box , prescribing info etc, It will have nice pictures and will attract those who have Parkinson's patients to start thinking about " Oh, there's a drug for that now ". Its a cost of doing business and well worth every penny.
I suspect Nuplazid is so new there are other specialist who will learn about it and be prescribing it by July. I get a few medical journals and haven't see on Nuplazid ad yet. Give it time. Investors in Biotech learn about new drugs sometimes sooner than the doc's in practice.
OK thanks for the info...12 mos. I hope you are wrong and its sooner, but I think they can still get close to a 1 Billion Rev in approx 2 yrs.
1) BUY OUT- Who knows when this could occur, but it will make your head spin when it hits.
2) Launch USA Nuplazid in June 2016
3) AD Psychosis Phase 2 Proof of Concept trial - Enrollment completed Mid 2016,
4) AD Psychosis Phase 2 Top line data reading out in the Q4 2016
5) AD Agitation Phase 2 on track to start Q2 2016
6) EU - Marketing Authorization Application (MAA) but still waiting for the Pediatric Investigation of Plan (PIP) waiver-this could take 4 mos, but I would bet no longer than 60d to get the waiver. Guessing EU Launch could occur in less than 6mos. Davis will provide updates on this issue.
I don't consider most Presentations a "catalysts " unless news is expected. Please feel free to make other suggests to my list. Less
But the EU MAA delay ,ie, no PIP Waiver notice was given to Acadia the day before the Pricing was made public. The EU didn't have a clue what the price was going to be. Forgive me, but maybe I am not understanding you.
I looked around on ema (dot) europa (dot) eu, but not to worry let us assume you are correct and I missed it. Point is Acadia is going for a Waiver.
Type Value Conf.
resist. 39.25 2
resist. 36.06 4
resist. 35.23 2
resist. 33.98 5
resist. 32.55 6
resist. 30.16 5
supp 28.30 5
supp 25.69 2
supp 24.52 2
supp 23.63 2
supp 21.76 2
supp 20.89 3
supp 19.23 2
supp 17.32 4
Recent CandleStick Analysis
May-06-2016 Homing Pigeon
Ind. short Inter Long
EMA Be VBe VBu
MACD VBe VBu VBu
Fibs Be Bu Bu
Highs Bu VBe VBe
Lows N N N
Trends N Bu N
Analysis Overall Short Intermediate Long
Neutral (0.07) Neutral (-0.05) Neutral (-0.01) Bullish (0.26)